Karsten Munk Knudsen nominated to Hempel board of directors
Chief Financial Officer (CFO) of Novo Nordisk, Karsten Munk Knudsen, has been nominated to replace Marianne Wiinholt as board member of Hempel.
At the AGM of Hempel on 29 April, Karsten Munk Knudsen will be put forward for election as member of the board of directors of Hempel. He joins Hempel’s Board at a time when the company has recently launched its new five year growth strategy „Double Impact“ according to which the company plans to double its revenue by 2025.
Marianne Wiinholt, CFO of Ørsted, has served on the Board and as chairman of the audit committee since April 2017. During this time, she has made valuable contributions with regard to developing Hempel’s financial foundation and governance structure.
Numerous positions within finance in Novo Nordisk
Karsten Munk Knudsen was appointed CFO of Novo Nordisk in 2018 and has held numerous positions within finance in Novo Nordisk and prior to this in NNIT and Nykredit. The entire Board of Directors of Hempel consists of nine members.
